When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
SRPT - 2 Reasons to be Optimistic About Biogen's Alzheimer's Drug
Sarepta Therapeutics Inc.
Biogen(NASDAQ: BIIB) shocked investors last year when it said it would submit its investigational Alzheimer's drug to the Food and Drug Administration for approval -- months after halting studies that showed the drug didn't work.
The biotech company explained its decision to file in early 2020 for regulatory approval, saying a look at broader data renewed its belief in aducanumab. The drug acts by binding to and eliminating beta amyloid, a protein that clings to neurons in the brains of Alzheimer's patients.